Ophthalmology Viscosurgical Devices Market size was valued at USD 360 million in the year 2020 and is anticipated to reach 458.02 million at a CAGR of 3.5% by 2027 during the forecast period 2021-2027. Cataracts are treated with ophthalmology viscosurgical devices (OVDs) with a minimal disturbance to the eye structure. These are solutions or agents which contain chemicals like methycellulose, hydroxypropyl, sodium hyaluronate and chondroitin sulfate. Ophthalmic Visco Surgical Devices are also called as viscoelastic agents that is a vital tool for the anterior segment surgeon. To create and maintain space in anterior chamber of eye during phacoemulsification and insertion of intraocular lens these ophthalmology visco surgical devices are used. These are the transparent and gel substances with elastic and viscous properties.
Ophthalmology Viscosurgical Devices market report gives comprehensive outlook on global market scenario, growth trends, shares, with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, end-user, and region. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyze the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include manufacturers, distributors, policy makers, and service providers engaged in Ophthalmology Viscosurgical Devices.